I don't mind a $50 deductible, I just want access and currently Cigna does not cover it, or at least last time I checked. When this changes, I agree, sales will massively increase. Until then, shorts can probably push the stock around in a weak market.
All Arena needs is a small investment by the BB's and the stock will double. Shorts flee like rats on an old ship when the BB's buy. Let's go ARNA, bring in some smart buyers! Or, maybe an activist that will remove JL, take control of the board and auction the co to the highest bidder will best serve the purposes of the shareholders. I don't mind waiting another year if they would communicate and show real progress. If they would do what they say and say what they will do just for once.
I'm sure if you post this question on the line site, people say Line. I have been adding to MEMP recently, they are hedged out 3 years. They don't seem as good as BBEP at ops/management, cost cutting and dealing with Wall street.
Hard to believe BBEP was $20+ in the past year. BBEP has the greatest discount to stated Book Value, and the largest coverage ratio, but who knows if that's accurate.
so, they have taken the low expense, slow approach to continuing development of Bel for smoking. Let's hope it yields something before patent expiration.
what can they do now, ACHN decided to partner with JNJ. I suppose they could go hostile and many of the shareholders/traders that bought high and those under water, basically everyone who bought stock in the past year, would probably support a hostile deal. I suppose they could buy the compound from JNJ and run their own combo trial. All of this seems unlikely.
of course, it's not pleasant, but a CEO is responsible to the shareholders first and JL is not being responsible with the resources we have provided. He needs to sell, or go!@
totally agree, they have tons of fat to cut and Jack is not man enough to make the tough decisions to save the company for the shareholders. They no longer have the money to do basic research. They only have money to try and get the lead compounds to a point of value and sell the company. Jack is clueless/in denial if he thinks he can keep up this game of making false promises, hype and dilute.
they don't need another over-paid bean counter, Hoffman was not a real CFO, he has no advanced business degree. He's just a highly over-paid yes-man for JL.
The original post is spot on, the silence is maddening!!! Cash is burning, progress is hard to find, something must be done, it appears nothing is being done, just continued cash burning with no recognizable value for the shareholders.
At the current burn rate (too high) they now have less than 2 years of cash and the ATM window is closed. People are now wise to JL's ST hype tricks. The only hope we have now is success in a mid-stage trial and a sale.
They need to radically reduce head count and all costs, other than for new trials, which can and for speed, should mostly be outsourced; to dress up the company for sale. So far I see no signs the JL has a clue about P&L, cash burn, corp governance...He thinks he's running a private co and the BOD is in his pocket (IMO). He's betting the company on success that might not come fast enough given the current high burn rate and stage of the pipeline.
doubtful, I'm adding on down days and swapping out of a less well hedged stock, to take my taxable losses in the other stock after 30 days from the last buy (stock substitution) and quality improvement.
Now they need to work hard to get costs down, so they can maintain the dividend for the next 2-3 years. Based on the hedges, I see no reason they can't maintain the current, large div. Added today.
When USO/Oil price was falling BBEP was going down 2x to 4x the % move in oil. When oil goes up, BBEP is not even keeping pace, at least today. Very strange in a bad way.